|
시장보고서
상품코드
1786334
세계의 피복 스텐트 시장Covered Stents |
||||||
Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
세계의 피복 스텐트 시장은 2030년까지 14억 달러에 도달
2024년에 11억 달러로 추정되는 세계의 피복 스텐트 시장은 2024-2030년의 분석 기간에 CAGR 3.3%로 성장하며, 2030년에는 14억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 혈관 스텐트는 CAGR 3.9%를 기록하며, 분석 기간 종료시에는 9억 9,170만 달러에 달할 것으로 예측됩니다. 비혈관 스텐트 부문의 성장률은 분석 기간 중 CAGR 1.9%로 추정됩니다.
미국 시장은 3억 1,090만 달러로 추정, 중국은 CAGR 6.3%로 성장 예측
미국의 피복 스텐트 시장은 2024년에 3억 1,090만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 분석 기간인 2024-2030년의 CAGR을 6.3%로, 2030년까지 2억 7,590만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 1.2%와 2.5%로 예측됩니다. 유럽에서는 독일이 CAGR 1.9%로 성장할 것으로 예측됩니다.
세계의 피복 스텐트 시장 - 주요 동향과 촉진요인 정리
피복 스텐트가 널리 사용되는 이유는 무엇인가? 심혈관 중재시술의 급격한 증가에 대한 검증
심혈관질환, 말초동맥질환(PAD), 동맥류 유병률 증가로 인해 전 세계 피복스텐트 시장은 크게 성장하고 있습니다. 저침습적 혈관중재술이 필요한 환자가 증가함에 따라 피복 스텐트는 재협착 및 혈관 파열에 대한 우수한 보호 기능을 제공하는 중요한 의료기기로 부상하고 있습니다. 동맥폐쇄와 동맥류에 취약한 고령화 인구 증가는 시장 수요를 더욱 촉진하고 있습니다. 또한 약제용출성 및 생체흡수성 등 스텐트 기술의 발전으로 치료 성적이 향상됨에 따라 중재적 심장 전문의들 사이에서 스텐트 시술이 선호되고 있습니다. 개복 수술에서 카테터 기반 중재시술로의 전환은 코팅된 스텐트가 복잡한 혈관 시술에 대한 최소 침습적 대안을 제공한다는 점에서 시장 확대의 원동력이 되고 있습니다. 동맥 질환의 조기 진단 및 치료에 대한 인식이 높아지고 의료비 지출이 증가하는 것도 시장 성장에 매우 중요한 역할을 하고 있습니다. 심혈관 건강 증진을 위한 정부 구상은 검진 프로그램 증가와 함께 피복 스텐트의 채택을 더욱 가속화하고 있습니다.
피복 스텐트의 주요 유형은 무엇인가? 소재별, 용도별 시장 세분화 분석
피복 스텐트 시장은 재료 구성, 디자인, 용도에 따라 분류되며, 각각은 특정 의료 요구 사항에 따라 분류됩니다. PTFE(폴리테트라플루오로에틸렌)와 ePTFE 코팅 스텐트는 생체 적합성, 유연성, 재협착을 최소화하는 능력으로 인해 가장 널리 사용되고 있습니다. 또 다른 주류는 폴리우레탄 코팅 스텐트로, 내구성과 혈전 형성에 대한 저항력으로 유명합니다. 적용 분야는 심혈관, 특히 대동맥류 및 관상동맥 질환의 치료에 널리 사용되고 있습니다. 경동맥, 대퇴동맥 치료를 포함한 말초혈관 치료에도 적용이 증가하고 있습니다. 또한 코팅된 스텐트는 내시경적 중재술, 특히 담관폐색 및 소화관 질환의 관리에 중요한 역할을 하고 있습니다. 자가 확장형 및 풍선 확장형 피복 스텐트의 개발로 치료 옵션이 더욱 다양해졌으며, 의사는 환자별 혈관 상태에 따라 최적의 장치를 선택할 수 있게 되었습니다. 금속 비계와 생체흡수성 폴리머 코팅을 결합한 하이브리드 스텐트 디자인의 채택이 증가하고 있는 것도 시장 성장에 기여하고 있습니다.
혁신은 어떻게 피복 스텐트의 미래를 주도하고 있는가? 생체 공학 및 스마트 스텐트 기술의 역할
코팅 스텐트 시장은 바이오소재과학, 생체공학, 스마트 의료기술의 발전으로 빠르게 진화하고 있습니다. 약제용출형 코팅 스텐트의 도입은 재협착 및 혈전증의 위험을 감소시켜 환자의 예후를 크게 개선했습니다. 항염증약 및 항균제를 포함한 나노테크놀러지 기반 코팅은 스텐트의 성능을 더욱 향상시키고 수술 후 합병증을 최소화합니다. 생분해성 스텐트 및 생체흡수성 스텐트의 출현은 혈관 치료의 획기적인 발전이며, 이러한 스텐트는 치료 목적을 달성하면 점차적으로 용해되어 장기적인 합병증을 제거합니다. 또한 AI를 활용한 영상처리와 로봇을 이용한 카테터 치료 기술로 스텐트 삽입의 정확도를 높이고 시술의 위험성을 낮추고 있습니다. 혈류를 모니터링하고 실시간으로 재협착을 감지할 수 있는 센서가 내장된 스마트 스텐트의 통합도 시장을 형성할 수 있는 획기적인 발전입니다. 3D 프린팅 기술로 혈관 적합성을 높이기 위한 환자별 맞춤형 스텐트 제작이 가능해지면서 맞춤형 의료 접근법도 각광받고 있습니다.
피복 스텐트 시장의 성장을 가속하는 요인은 무엇인가? 주요 시장 성장 촉진요인에 대한 설명
피복 스텐트 시장의 성장은 심혈관 질환의 유병률 증가, 스텐트 설계의 기술 발전, 최소 침습적 시술의 채택 증가 등 여러 요인에 기인합니다. 신흥 국가의 의료 인프라 확충은 중재적 심장학 치료에 대한 접근성을 향상시켜 시장 수요를 더욱 촉진하고 있습니다. 심혈관계 질환에 대한 부담 경감을 위한 정부의 우호적인 보험급여 정책 및 정부의 구상도 코팅 스텐트 도입을 촉진하고 있습니다. 또한 차세대 스텐트 기술에 초점을 맞춘 임상시험 증가는 기술 혁신을 촉진하고 보다 안전하고 효과적인 장치 개발로 이어지고 있습니다. 비용 효율성과 빠른 회복 시간을 배경으로 외래 환자 시술이 선호되고 있는 점도 시장을 더욱 확대시키고 있습니다. 스텐트 재료, 디지털 헬스 통합, 개인 맞춤형 혈관 솔루션의 지속적인 발전으로 세계 피복 스텐트 시장은 지속적인 성장을 통해 환자 결과 개선과 의료 효율성 향상을 실현할 것으로 예측됩니다.
부문
제품(혈관 스텐트, 비혈관 스텐트), 최종사용자(병원 최종사용자, 외래 의료 센터 최종사용자, 전문 클리닉 최종사용자)
조사 대상 기업의 예
- Abbott Laboratories
- Alvimedica
- AndraTec GmbH
- Artivion, Inc.
- B. Braun Interventional Systems, Inc.
- BD Interventional
- Bentley InnoMed GmbH
- Biosensors International Group, Ltd.
- Biotronik AG
- Boston Scientific Corporation
- Cook Medical
- Cordis(a Cardinal Health company)
- Getinge AB
- Gore Medical(W. L. Gore & Associates)
- iVascular S.L.U.
- Lepu Medical Technology Co., Ltd.
- Medtronic plc
- Meril Life Sciences Pvt. Ltd.
- MicroPort Scientific Corporation
- Terumo Corporation
AI 통합
당사는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.
Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 큐레이트된 컨텐츠 리포지토리를 구축했습니다.
관세 영향 계수
Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.
목차
제1장 조사 방법
제2장 개요
- 시장 개요
- 주요 기업
- 시장 동향과 촉진요인
- 세계 시장 전망
제3장 시장 분석
- 미국
- 캐나다
- 일본
- 중국
- 유럽
- 프랑스
- 독일
- 이탈리아
- 영국
- 스페인
- 러시아
- 기타 유럽
- 아시아태평양
- 호주
- 인도
- 한국
- 기타 아시아태평양
- 라틴아메리카
- 아르헨티나
- 브라질
- 멕시코
- 기타 라틴아메리카
- 중동
- 이란
- 이스라엘
- 사우디아라비아
- 아랍에미리트
- 기타 중동
- 아프리카
제4장 경쟁
KSA 25.08.14Global Covered Stents Market to Reach US$1.4 Billion by 2030
The global market for Covered Stents estimated at US$1.1 Billion in the year 2024, is expected to reach US$1.4 Billion by 2030, growing at a CAGR of 3.3% over the analysis period 2024-2030. Vascular Stent, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$991.7 Million by the end of the analysis period. Growth in the Non-vascular Stent segment is estimated at 1.9% CAGR over the analysis period.
The U.S. Market is Estimated at US$310.9 Million While China is Forecast to Grow at 6.3% CAGR
The Covered Stents market in the U.S. is estimated at US$310.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$275.9 Million by the year 2030 trailing a CAGR of 6.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.2% and 2.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.9% CAGR.
Global Covered Stents Market - Key Trends & Drivers Summarized
Why Are Covered Stents Gaining Widespread Adoption? Examining the Surge in Cardiovascular Interventions
The global covered stents market has witnessed significant growth due to the rising prevalence of cardiovascular diseases, peripheral artery disease (PAD), and aneurysms. With an increasing number of patients requiring minimally invasive vascular interventions, covered stents have emerged as a critical medical device, offering superior protection against restenosis and vessel rupture. The growing aging population, which is more susceptible to arterial blockages and aneurysms, has further fueled market demand. Additionally, advancements in stent technology, including drug-eluting and bioresorbable covered stents, have enhanced treatment outcomes, making these devices a preferred choice among interventional cardiologists. The shift from open surgeries to catheter-based interventions has driven market expansion, as covered stents provide a less invasive alternative for complex vascular procedures. Rising awareness regarding early diagnosis and treatment of arterial diseases, coupled with an increase in healthcare expenditures, has also played a pivotal role in the market’s growth. Government initiatives promoting cardiovascular health, along with increased screening programs, have further accelerated the adoption of covered stents.
What Are the Leading Types of Covered Stents? Analyzing Market Segmentation by Material & Application
The covered stents market is categorized based on material composition, design, and application, each catering to specific medical requirements. PTFE (polytetrafluoroethylene) and ePTFE-covered stents are among the most widely used due to their biocompatibility, flexibility, and ability to minimize restenosis. Another dominant category is polyurethane-covered stents, known for their durability and ability to resist thrombus formation. In terms of applications, covered stents are extensively used in cardiovascular procedures, particularly in treating aortic aneurysms and coronary artery disease. Peripheral vascular applications, including the treatment of carotid and femoral arteries, have also witnessed increased adoption. Additionally, covered stents play a vital role in endoscopic interventions, particularly for managing bile duct obstructions and gastrointestinal tract diseases. The development of self-expanding and balloon-expandable covered stents has further diversified treatment options, allowing physicians to select the most appropriate device based on patient-specific vascular conditions. The rising adoption of hybrid stent designs, which combine metal scaffolding with bioresorbable polymer coatings, has also contributed to market growth.
How Is Innovation Driving the Future of Covered Stents? The Role of Bioengineering & Smart Stent Technologies
The covered stents market is rapidly evolving, driven by advancements in biomaterial science, bioengineering, and smart medical technologies. The introduction of drug-eluting covered stents has significantly improved patient outcomes by reducing the risk of restenosis and thrombosis. Nanotechnology-based coatings, including anti-inflammatory and antimicrobial agents, have further enhanced stent performance, minimizing post-procedural complications. The emergence of biodegradable and bioresorbable stents represents a breakthrough in vascular treatment, as these stents gradually dissolve after fulfilling their therapeutic purpose, eliminating long-term complications. Additionally, AI-powered imaging and robotic-assisted catheterization techniques have improved precision in stent placement, reducing procedural risks. The integration of smart stents with embedded sensors capable of monitoring blood flow and detecting restenosis in real-time is another revolutionary advancement shaping the market. Personalized medicine approaches are also gaining traction, with 3D printing technology enabling patient-specific stent customization for enhanced vascular compatibility.
What’s Fueling the Growth of the Covered Stents Market? Key Market Drivers Explained
The growth in the covered stents market is driven by several factors, including the rising prevalence of cardiovascular diseases, technological advancements in stent design, and increasing adoption of minimally invasive procedures. The expansion of healthcare infrastructure in emerging economies has improved access to interventional cardiology treatments, further propelling market demand. Favorable reimbursement policies and government initiatives aimed at reducing the burden of cardiovascular diseases have also encouraged the adoption of covered stents. Additionally, the growing number of clinical trials focused on next-generation stent technologies has fueled innovation, leading to the development of safer and more effective devices. The increasing preference for outpatient procedures, driven by cost-effectiveness and faster recovery times, has further expanded the market. With continuous advancements in stent materials, digital health integration, and personalized vascular solutions, the global covered stents market is expected to witness sustained growth, offering improved patient outcomes and enhanced healthcare efficiency.
SCOPE OF STUDY:
The report analyzes the Covered Stents market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Product (Vascular Stent, Non-vascular Stent); End-Use (Hospitals End-Use, Ambulatory Care Centers End-Use, Specialty Clinics End-Use)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Select Competitors (Total 36 Featured) -
- Abbott Laboratories
- Alvimedica
- AndraTec GmbH
- Artivion, Inc.
- B. Braun Interventional Systems, Inc.
- BD Interventional
- Bentley InnoMed GmbH
- Biosensors International Group, Ltd.
- Biotronik AG
- Boston Scientific Corporation
- Cook Medical
- Cordis (a Cardinal Health company)
- Getinge AB
- Gore Medical (W. L. Gore & Associates)
- iVascular S.L.U.
- Lepu Medical Technology Co., Ltd.
- Medtronic plc
- Meril Life Sciences Pvt. Ltd.
- MicroPort Scientific Corporation
- Terumo Corporation
AI INTEGRATIONS
We're transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
- 1. MARKET OVERVIEW
- Influencer Market Insights
- Tariff Impact on Global Supply Chain Patterns
- Covered Stents - Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
- 2. FOCUS ON SELECT PLAYERS
- 3. MARKET TRENDS & DRIVERS
- Rising Incidence of Cardiovascular Diseases Propels Demand for Covered Stents in Vascular Interventions
- Technological Advancements in Biocompatible Materials Strengthen the Business Case for Enhanced Covered Stents
- Increasing Adoption of Minimally Invasive Procedures Expands Addressable Market for Covered Stents in Treatment Protocols
- Growing Focus on Long-Term Durability and Reduced Re-Stenosis Rates Drives Demand for High-Performance Covered Stents
- Surge in Diabetic and Aging Populations Accelerates Market Growth for Covered Stents in Peripheral Artery Disease (PAD) Treatment
- Regulatory Approvals for New Covered Stent Designs Accelerate Market Penetration and Adoption
- Demand for Customizable, Patient-Specific Stent Solutions Expands Opportunity for Tailored Covered Stent Technologies
- Advances in Coating Technologies Drive Adoption of Drug-Eluting Covered Stents, Expanding Treatment Options
- Increasing Focus on Global Healthcare Access and Affordability Strengthens Market for Cost-Effective Covered Stent Solutions
- Expansion of Hybrid Procedures Combining Stent Implants with Other Therapeutic Interventions Generates New Market Opportunities
- Rising Number of Coronary Artery Bypass Surgeries Strengthens Growth for Covered Stents as an Alternative to Traditional Surgery
- Emergence of Hybrid Stent Materials Drives Innovation in Multi-Layered Covered Stents with Enhanced Healing Properties
- Regulatory Pressure to Improve Post-Surgery Outcomes Drives Innovation in Stent Coatings and Bio-Absorbable Technologies
- Increasing Number of Healthcare Institutions Investing in Advanced Cardiovascular Technologies Expands Market Reach
- Rising Global Health Awareness and Preventative Care Initiatives Drive Early Adoption of Covered Stents for At-Risk Populations
- Competition in the Medical Device Industry Stimulates Innovation in Covered Stent Designs to Meet Evolving Clinical Needs
- Rising Incidence of Complex Aortic and Endovascular Diseases Spurs Demand for Specialized Covered Stent Solutions
- Integration of Artificial Intelligence in Medical Imaging and Procedure Planning Enhances Adoption of Covered Stents in Precision Medicine
- Surge in Clinical Research and Trials for Covered Stents Expands Market Understanding and Adoption of New Treatments
- Focus on Reducing Healthcare Costs and Improving Patient Outcomes Drives Growth of Covered Stents with Shorter Recovery Times and Fewer Complications
- 4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Covered Stents Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
- TABLE 2: World Recent Past, Current & Future Analysis for Covered Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 3: World Historic Review for Covered Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 4: World 15-Year Perspective for Covered Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
- TABLE 5: World Recent Past, Current & Future Analysis for Vascular Stent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 6: World Historic Review for Vascular Stent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 7: World 15-Year Perspective for Vascular Stent by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 8: World Recent Past, Current & Future Analysis for Non-vascular Stent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 9: World Historic Review for Non-vascular Stent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 10: World 15-Year Perspective for Non-vascular Stent by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 11: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 12: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 13: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Care Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 15: World Historic Review for Ambulatory Care Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 16: World 15-Year Perspective for Ambulatory Care Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 17: World Recent Past, Current & Future Analysis for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 18: World Historic Review for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 19: World 15-Year Perspective for Specialty Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
- UNITED STATES
- Covered Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
- TABLE 20: USA Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 21: USA Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 22: USA 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
- TABLE 23: USA Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 24: USA Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 25: USA 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
- CANADA
- TABLE 26: Canada Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 27: Canada Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 28: Canada 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
- TABLE 29: Canada Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 30: Canada Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 31: Canada 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
- JAPAN
- Covered Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
- TABLE 32: Japan Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 33: Japan Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 34: Japan 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
- TABLE 35: Japan Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 36: Japan Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 37: Japan 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
- CHINA
- Covered Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
- TABLE 38: China Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 39: China Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 40: China 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
- TABLE 41: China Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 42: China Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 43: China 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
- EUROPE
- Covered Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
- TABLE 44: Europe Recent Past, Current & Future Analysis for Covered Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 45: Europe Historic Review for Covered Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 46: Europe 15-Year Perspective for Covered Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
- TABLE 47: Europe Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 48: Europe Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 49: Europe 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
- TABLE 50: Europe Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 51: Europe Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 52: Europe 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
- FRANCE
- Covered Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
- TABLE 53: France Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 54: France Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 55: France 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
- TABLE 56: France Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 57: France Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 58: France 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
- GERMANY
- Covered Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
- TABLE 59: Germany Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 60: Germany Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 61: Germany 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
- TABLE 62: Germany Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 63: Germany Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 64: Germany 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
- ITALY
- TABLE 65: Italy Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 66: Italy Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 67: Italy 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
- TABLE 68: Italy Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 69: Italy Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 70: Italy 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
- UNITED KINGDOM
- Covered Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
- TABLE 71: UK Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 72: UK Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 73: UK 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
- TABLE 74: UK Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 75: UK Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 76: UK 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
- SPAIN
- TABLE 77: Spain Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 78: Spain Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 79: Spain 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
- TABLE 80: Spain Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 81: Spain Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 82: Spain 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
- RUSSIA
- TABLE 83: Russia Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 84: Russia Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 85: Russia 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
- TABLE 86: Russia Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 87: Russia Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 88: Russia 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
- REST OF EUROPE
- TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 90: Rest of Europe Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 91: Rest of Europe 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
- TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 93: Rest of Europe Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 94: Rest of Europe 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
- ASIA-PACIFIC
- Covered Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
- TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Covered Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 96: Asia-Pacific Historic Review for Covered Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 97: Asia-Pacific 15-Year Perspective for Covered Stents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
- TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 99: Asia-Pacific Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 100: Asia-Pacific 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
- TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 102: Asia-Pacific Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 103: Asia-Pacific 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
- AUSTRALIA
- Covered Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
- TABLE 104: Australia Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 105: Australia Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 106: Australia 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
- TABLE 107: Australia Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 108: Australia Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 109: Australia 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
- INDIA
- Covered Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
- TABLE 110: India Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 111: India Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 112: India 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
- TABLE 113: India Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 114: India Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 115: India 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
- SOUTH KOREA
- TABLE 116: South Korea Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 117: South Korea Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 118: South Korea 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
- TABLE 119: South Korea Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 120: South Korea Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 121: South Korea 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
- REST OF ASIA-PACIFIC
- TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 123: Rest of Asia-Pacific Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 124: Rest of Asia-Pacific 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
- TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 126: Rest of Asia-Pacific Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
- LATIN AMERICA
- Covered Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
- TABLE 128: Latin America Recent Past, Current & Future Analysis for Covered Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 129: Latin America Historic Review for Covered Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 130: Latin America 15-Year Perspective for Covered Stents by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
- TABLE 131: Latin America Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 132: Latin America Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 133: Latin America 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
- TABLE 134: Latin America Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 135: Latin America Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 136: Latin America 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
- ARGENTINA
- TABLE 137: Argentina Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 138: Argentina Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 139: Argentina 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
- TABLE 140: Argentina Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 141: Argentina Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 142: Argentina 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
- BRAZIL
- TABLE 143: Brazil Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 144: Brazil Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 145: Brazil 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
- TABLE 146: Brazil Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 147: Brazil Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 148: Brazil 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
- MEXICO
- TABLE 149: Mexico Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 150: Mexico Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 151: Mexico 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
- TABLE 152: Mexico Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 153: Mexico Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 154: Mexico 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
- REST OF LATIN AMERICA
- TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 156: Rest of Latin America Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 157: Rest of Latin America 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
- TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 159: Rest of Latin America Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 160: Rest of Latin America 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
- MIDDLE EAST
- Covered Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
- TABLE 161: Middle East Recent Past, Current & Future Analysis for Covered Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 162: Middle East Historic Review for Covered Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 163: Middle East 15-Year Perspective for Covered Stents by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
- TABLE 164: Middle East Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 165: Middle East Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 166: Middle East 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
- TABLE 167: Middle East Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 168: Middle East Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 169: Middle East 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
- IRAN
- TABLE 170: Iran Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 171: Iran Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 172: Iran 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
- TABLE 173: Iran Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 174: Iran Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 175: Iran 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
- ISRAEL
- TABLE 176: Israel Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 177: Israel Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 178: Israel 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
- TABLE 179: Israel Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 180: Israel Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 181: Israel 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
- SAUDI ARABIA
- TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 183: Saudi Arabia Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 184: Saudi Arabia 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
- TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 186: Saudi Arabia Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 187: Saudi Arabia 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
- UNITED ARAB EMIRATES
- TABLE 188: UAE Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 189: UAE Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 190: UAE 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
- TABLE 191: UAE Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 192: UAE Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 193: UAE 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
- REST OF MIDDLE EAST
- TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 195: Rest of Middle East Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 196: Rest of Middle East 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
- TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 198: Rest of Middle East Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 199: Rest of Middle East 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
- AFRICA
- Covered Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
- TABLE 200: Africa Recent Past, Current & Future Analysis for Covered Stents by Product - Vascular Stent and Non-vascular Stent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 201: Africa Historic Review for Covered Stents by Product - Vascular Stent and Non-vascular Stent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 202: Africa 15-Year Perspective for Covered Stents by Product - Percentage Breakdown of Value Sales for Vascular Stent and Non-vascular Stent for the Years 2015, 2025 & 2030
- TABLE 203: Africa Recent Past, Current & Future Analysis for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 204: Africa Historic Review for Covered Stents by End-Use - Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 205: Africa 15-Year Perspective for Covered Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Care Centers End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
IV. COMPETITION
샘플 요청 목록